Modification of occupational exposures on bladder cancer risk by common genetic polymorphisms

Journal of the National Cancer Institute

Volumn 107, Issue 11, 2015, Pages

  Figueroa, Jonine D ^a,d   Koutros, Stella ^a   Colt, Joanne S ^a   Kogevinas, Manolis ^e,f,g   Garcia Closas, Montserrat ^h   Real, Francisco X ^i,j   Friesen, Melissa C ^a   Baris, Dalsu ^a   Stewart, Patricia ^a   Schwenn, Molly ^k   Johnson, Alison ^l   Karagas, Margaret R ^m   Armenti, Karla R ⁿ   Moore, Lee E ^a   Schned, Alan ^m   Lenz, Petra ^o   Prokunina Olsson, Ludmila ^a   Banday, A Rouf ^a   Paquin, Ashley ^a   Ylaya, Kris ^b   Chung, Joon Yong ^b   Hewitt, Stephen M ^b   Nickerson, Michael L ^c   Tardón, Adonina ^e,p   Serra, Consol ^j   Carrato, Alfredo ^q   García Closas, Reina ^r   Lloreta, Josep ^e   Malats, Núria ⁱ   Fraumeni, Joseph F ^a   Chanock, Stephen J ^a   Chatterjee, Nilanjan ^a   Rothman, Nathaniel ^a   Silverman, Debra T ^a   more..

^a Div of Cancer Epidemiol and Genet   (United States)

^b Center for Cancer Research   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

^d UNIVERSITY OF EDINBURGH   (United Kingdom)

^e CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^f CENTRE FOR RESEARCH IN ENVIRONMENTAL EPIDEMIOLOGY CREAL   (Spain)

^g INST MUNIC D INVESTIGACIO MEDICA   (Spain)

^h INSTITUTE OF CANCER RESEARCH   (United Kingdom)

ⁱ Centro Nacional de Investigaciones Oncológicas   (Spain)

^j UNIVERSITAT POMPEU FABRA   (Spain)

^k Maine Cancer Registry   (United States)

^l Vermont Cancer Registry   (United States)

^m DARTMOUTH MEDICAL SCHOOL   (United States)

ⁿ NEW HAMPSHIRE DEPARTMENT OF HEALTH AND HUMAN SERVICES   (United States)

^o FREDERICK NATIONAL LABORATORY FOR CANCER RESEARCH   (United States)

^p UNIVERSITY OF OVIEDO   (Spain)

^q HOSPITAL RAMÓN Y CAJAL   (Spain)

^r HOSPITAL UNIVERSITARIO DE CANARIAS   (Spain)

more..

Author keywords

[No Author keywords available]

Indexed keywords

FIBROBLAST GROWTH FACTOR RECEPTOR 3; TOBACCO SMOKE; FGFR3 PROTEIN, HUMAN; GLUCURONOSYLTRANSFERASE; GLUTATHIONE S-TRANSFERASE M1; GLUTATHIONE TRANSFERASE; MICROTUBULE ASSOCIATED PROTEIN; TACC3 PROTEIN, HUMAN; TMEM129 PROTEIN, HUMAN; UBIQUITIN PROTEIN LIGASE; UGT1A1 ENZYME;

ALLELE; ARTICLE; BLADDER CANCER; CANCER PATIENT; CANCER RISK; ENVIRONMENTAL EXPOSURE; GENETIC POLYMORPHISM; GENETIC VARIATION; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE ENVIRONMENT INTERACTION; HIGH RISK PATIENT; HUMAN; IMMUNOHISTOCHEMISTRY; OCCUPATIONAL EXPOSURE; PRIORITY JOURNAL; ADULT; ADVERSE EFFECTS; AGED; FEMALE; GENE DELETION; GENETIC PREDISPOSITION; GENETICS; GERMLINE MUTATION; MALE; METALLURGY; MIDDLE AGED; OCCUPATIONAL DISEASES; QUESTIONNAIRE; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; UNITED KINGDOM; URINARY BLADDER NEOPLASMS;

ADULT; AGED; FEMALE; GENE DELETION; GENE-ENVIRONMENT INTERACTION; GENETIC PREDISPOSITION TO DISEASE; GERM-LINE MUTATION; GLUCURONOSYLTRANSFERASE; GLUTATHIONE TRANSFERASE; HUMANS; MALE; METALLURGY; MICROTUBULE-ASSOCIATED PROTEINS; MIDDLE AGED; OCCUPATIONAL DISEASES; OCCUPATIONAL EXPOSURE; POLYMORPHISM, SINGLE NUCLEOTIDE; QUESTIONNAIRES; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 3; RISK FACTORS; SCOTLAND; UBIQUITIN-PROTEIN LIGASES; URINARY BLADDER NEOPLASMS;

EID: 84946203061     PISSN: 00278874     EISSN: 14602105     Source Type: Journal    
DOI: 10.1093/jnci/djv223     Document Type: Article

References (22)

1. Silverman DT, Devessa SS, Moore L, et al. Bladder Cancer. In: Fraumeni JF, Jr. and Schottenfeld D, (ed). Cancer Epidemiology and Prevention Third Edition. Third Edition ed. New York, NY: Oxford University Press; 2006, 1101-1127.
2. Colt JS, Karagas MR, Schwenn M, et al. Occupation and bladder cancer in a population-based case-control study in Northern New England. Occup Environ Med. 2011;68(4):239-249.
3. Samanic CM, Kogevinas M, Silverman DT, et al. Occupation and bladder cancer in a hospital-based case-control study in Spain. Occup Environ Med. 2008;65(5):347-353.
4. Figueroa JD, Ye Y, Siddiq A, et al. Genome-wide association study identifies multiple loci associated with bladder cancer risk. Hum Mol Genet. 2014;23(5):1387-1398.
5. Garcia-Closas M, Rothman N, Figueroa JD, et al. Common Genetic Polymorphisms Modify the Effect of Smoking on Absolute Risk of Bladder Cancer. Cancer Res. 2013;73(7):2211-2220.
6. Baris D, Karagas MR, Verrill C, et al. A case-control study of smoking and bladder cancer risk: emergent patterns over time. J Natl Cancer Inst. 2009;101(22):1553-1561.
7. Garcia-Closas M, Malats N, Silverman D, et al. NAT2 slow acetylation, GSTM1 null genotype, and risk of bladder cancer: results from the Spanish Bladder Cancer Study and meta-analyses. Lancet. 2005;366(9486):649-659.
8. Colt JS, Friesen MC, Stewart P, et al. A Case-Control Study of Occupational Exposure to Metalworking Fluids and Bladder Cancer Risk. Occup Environ Med. 2014;71:667-674.
9. Garcia-Closas M, Ye Y, Rothman N, et al. A genome-wide association study of bladder cancer identifies a new susceptibility locus within SLC14A1, a urea transporter gene on chromosome 18q12. 3. Hum Mol Genet. 2011;20(21):4282-4289.
10. Kiemeney LA, Sulem P, Besenbacher S, et al. A sequence variant at 4p16. 3 confers susceptibility to urinary bladder cancer. Nat Genet. 2010;42(5):415-419.
11. Kiemeney LA, Thorlacius S, Sulem P, et al. Sequence variant on 8q24 confers susceptibility to urinary bladder cancer. Nat Genet. 2008;40(11):1307-1312.
12. Rafnar T, Sulem P, Stacey SN, et al. Sequence variants at the TERT-CLPTM1L locus associate with many cancer types. Nat Genet. 2009;41(2):221-227.
13. Rafnar T, Vermeulen SH, Sulem P, et al. European genome-wide association study identifies SLC14A1 as a new urinary bladder cancer susceptibility gene. Hum Mol Genet. 2011;20(21):4268-4281.
14. Rothman N, Garcia-Closas M, Chatterjee N, et al. A multi-stage genome-wide association study of bladder cancer identifies multiple susceptibility loci. Nat Genet. 2010;42(11):978-984.
15. Tang W, Fu YP, Figueroa JD, et al. Mapping of the UGT1A locus identifies an uncommon coding variant that affects mRNA expression and protects from bladder cancer. Hum Mol Genet. 2012;21(8):1918-1930.
16. Wu X, Ye Y, Kiemeney LA, et al. Genetic variation in the prostate stem cell antigen gene PSCA confers susceptibility to urinary bladder cancer. Nat Genet. 2009;41(9):991-995.
17. Garcia-Closas M, Hein DW, Silverman D, et al. A single nucleotide polymorphism tags variation in the arylamine N-acetyltransferase 2 phenotype in populations of European background. Pharmacogenet Genomics. 2011;21(4):231-236.
18. Han SS, Rosenberg PS, Garcia-Closas M, et al. Likelihood ratio test for detecting gene (G)-environment (E) interactions under an additive risk model exploiting G-E independence for case-control data. Am J Epidemiol. 2012;176(11):1060-1067.
19. Petracci E, Decarli A, Schairer C, et al. Risk factor modification and projections of absolute breast cancer risk. J Natl Cancer Inst. 2011;103(13):1037-1048.
20. Engel LS, Taioli E, Pfeiffer R, et al. Pooled analysis and meta-analysis of glutathione S-transferase M1 and bladder cancer: a HuGE review. Am J Epidemiol. 2002;156(2):95-109.
21. Golka K, Reckwitz T, Kempkes M, et al. N-Acetyltransferase 2 (NAT2) and Glutathione S-Transferase micro (GSTM1) in Bladder-cancer Patients in a Highly Industrialized Area. Int J Occup Environ Health 1997;3(2):105-110.
22. Golka K, Hermes M, Selinski S, et al. Susceptibility to urinary bladder cancer: relevance of rs9642880[T], GSTM1 0/0 and occupational exposure. Pharmacogenet Genomics 2009;19(11):903-6.